Erratum: Role of platelets, neutrophils, and factor XII in spontaneous venous thrombosis in mice (Blood. (2016) 127: 21 (2630-2637) DOI: 10.1182/blood-2015-10-672766);Role of platelets, neutrophils, and factor XII in spontaneous venous thrombosis in mice

Blood

Volumn 127, Issue 21, 2016, Pages 2630-2637

  Heestermans, Marco ^a,b   Salloum Asfar, Salam ^a,b   Salvatori, Daniela ^a   Laghmani, El Houari ^a   Luken, Brenda M ^c   Zeerleder, Sacha S ^c   Spronk, Henri M H ^d   Korporaal, Suzanne J ^e   Wagenaar, Gerry T M ^a   Reitsma, Pieter H ^a,b   Van Vlijmen, Bart J M ^a,b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Division of Thrombosis and Hemostasis   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

^d MAASTRICHT UNIVERSITY   (Netherlands)

^e UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN III; BLOOD CLOTTING FACTOR 12; SMALL INTERFERING RNA; FIBRIN; LY ANTIGEN; LY6G ANTIGEN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD CLOTTING; CLINICAL FEATURE; CONTROLLED STUDY; EXTRACELLULAR TRAP; FEMALE; FIBRIN DEPOSITION; GENE EXPRESSION; MOUSE; NEUTROPHIL; NONHUMAN; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; SPONTANEOUS VENOUS THROMBOSIS; THROMBIN TIME; THROMBOCYTE; THROMBOCYTE COUNT; VEIN THROMBOSIS; ANIMAL; ANTAGONISTS AND INHIBITORS; LIVER; METABOLISM; PATHOLOGY;

ANIMALS; ANTIGENS, LY; ANTITHROMBIN III; BLOOD PLATELETS; FACTOR XII; FEMALE; FIBRIN; LIVER; MICE; NEUTROPHILS; RNA, SMALL INTERFERING; VENOUS THROMBOSIS;

EID: 84974533921     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2018-05-854596     Document Type: Erratum

References (32)

1. von Brühl ML, Stark K, Steinhart A, et al. Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo. J Exp Med. 2012;209(4):819-835.
2. Geddings JE, Mackman N. New players in haemostasis and thrombosis. Thromb Haemost. 2014;111(4):570-574.
3. Geddings J, Aleman MM, Wolberg A, von Brühl ML, Massberg S, Mackman N. Strengths and weaknesses of a new mouse model of thrombosis induced by inferior vena cava stenosis: communication from the SSC of the ISTH. J Thromb Haemost. 2014;12(4):571-573.
4. Martinelli I. Risk factors in venous thromboembolism. Thromb Haemost. 2001;86(1):395-403.
5. Dahlbäck B. Advances in understanding pathogenic mechanisms of thrombophilic disorders. Blood. 2008;112(1):19-27.
6. Safdar H, Cheung KL, Salvatori D, et al. Acute and severe coagulopathy in adult mice following silencing of hepatic antithrombin and protein C production. Blood. 2013;121(21):4413-4416.
7. Rosenberg RD, Aird WC. Vascular-bed - specific hemostasis and hypercoagulable states. N Engl J Med. 1999;340(20):1555-1564.
8. Safdar H, Cheung KL, Vos HL, et al. Modulation of mouse coagulation gene transcription following acute in vivo delivery of synthetic small interfering RNAs targeting HNF4α and C/EBPα. PLoS One. 2012;7(6):e38104.
9. Cleuren ACA, Van der Linden IK, De Visser YP, Wagenaar GTM, Reitsma PH, Van Vlijmen BJM. 17α-Ethinylestradiol rapidly alters transcript levels of murine coagulation genes via estrogen receptor α. J Thromb Haemost. 2010;8(8):1838-1846.
10. de Visser YP, Walther FJ, Laghmani EH, van der Laarse A, Wagenaar GT. Apelin attenuates hyperoxic lung and heart injury in neonatal rats. Am J Respir Crit Care Med. 2010;182(10):1239-1250.
11. Kooijman S, Meurs I, van der Stoep M, et al. Hematopoietic α7 nicotinic acetylcholine receptor deficiency increases inflammation and platelet activation status, but does not aggravate atherosclerosis. J Thromb Haemost. 2015;13(1):126-135.
12. Zeerleder S, Zwart B, te Velthuis H, et al. A plasma nucleosome releasing factor (NRF) with serine protease activity is instrumental in removal of nucleosomes from secondary necrotic cells. FEBS Lett. 2007;581(28):5382-5388.
13. Hemker HC, Giesen P, AlDieri R, et al. The calibrated automated thrombogram (CAT): a universal routine test for hyper- and hypocoagulability. Pathophysiol Haemost Thromb. 2002;32(5-6):249-253.
14. Mangin P, Yap CL, Nonne C, et al. Thrombin overcomes the thrombosis defect associated with platelet GPVI/FcRgamma deficiency. Blood. 2006;107(11):4346-4353.
15. Brill A, Fuchs TA, Chauhan AK, et al. von Willebrand factor-mediated platelet adhesion is critical for deep vein thrombosis in mouse models. Blood. 2011;117(4):1400-1407.
16. Becattini C, Agnelli G, Schenone A, et al; WARFASA Investigators. Aspirin for preventing the recurrence of venous thromboembolism. N Engl J Med. 2012;366(21):1959-1967.
17. Warkentin TE. Aspirin for dual prevention of venous and arterial thrombosis. N Engl J Med. 2012;367(21):2039-2041.
18. Brinkmann V, Zychlinsky A. Neutrophil extracellular traps: is immunity the second function of chromatin? J Cell Biol. 2012;198(5):773-783.
19. Martinod K, Wagner DD. Thrombosis: tangled up in NETs. Blood. 2014;123(18):2768-2776.
20. Diaz JA, Alvarado CM, Wrobleski SK, et al. The electrolytic inferior vena cava model (EIM) to study thrombogenesis and thrombus resolution with continuous blood flow in the mouse. Thromb Haemost. 2013;109(6):1158-1169.
21. Savchenko AS, Martinod K, Seidman MA, et al. Neutrophil extracellular traps form predominantly during the organizing stage of human venous thromboembolism development. J Thromb Haemost. 2014;12(6):860-870.
22. van Montfoort ML, Stephan F, Lauw MN, et al. Circulating nucleosomes and neutrophil activation as risk factors for deep vein thrombosis. Arterioscler Thromb Vasc Biol. 2013;33(1):147-151.
23. Gailani D, Renné T. Intrinsic pathway of coagulation and arterial thrombosis. Arterioscler Thromb Vasc Biol. 2007;27(12):2507-2513.
24. Müller F, Gailani D, Renné T. Factor XI and XII as antithrombotic targets. Curr Opin Hematol. 2011;18(5):349-355.
25. Konings J, Hoving LR, Ariëns RS, et al. The role of activated coagulation factor XII in overall clot stability and fibrinolysis. Thromb Res. 2015;136(2):474-480.
26. Konings J, Govers-Riemslag JWP, Philippou H, et al. Factor XIIa regulates the structure of the fibrin clot independently of thrombin generation through direct interaction with fibrin. Blood. 2011;118(14):3942-3951.
27. Renné T, Nieswandt B, Gailani D. The intrinsic pathway of coagulation is essential for thrombus stability in mice. Blood Cells Mol Dis. 2006;36(2):148-151.
28. Müller F, Mutch NJ, Schenk WA, et al. Platelet polyphosphates are proinflammatory and procoagulant mediators in vivo. Cell. 2009;139(6):1143-1156.
29. Nielsen VG, Cohen BM, Cohen E. Effects of coagulation factor deficiency on plasma coagulation kinetics determined via thrombelastography: critical roles of fibrinogen and factors II, VII, X and XII. Acta Anaesthesiol Scand. 2005;49(2):222-231.
30. Kenne E, Nickel KF, Long AT, et al. Factor XII: a novel target for safe prevention of thrombosis and inflammation. J Intern Med. 2015;278(6):571-585.
31. Schmaier AH. The contact activation and kallikrein/kinin systems: pathophysiologic and physiologic activities. J Thromb Haemost. 2016;14(1):28-39.
32. Björkqvist J, de Maat S, Lewandrowski U, et al. Defective glycosylation of coagulation factor XII underlies hereditary angioedema type III. J Clin Invest. 2015;125(8):3132-3146.